|

Delayed Selective Sentinel Node Biopsy for Patients Undergoing Mastectomy for DCIS

RECRUITINGN/ASponsored by Seoul National University Hospital
Actively Recruiting
PhaseN/A
SponsorSeoul National University Hospital
Started2023-06-13
Est. completion2025-04-28
Eligibility
Age20 Years – 75 Years
Healthy vol.Accepted

Summary

In the case of a patient undergoing total mastectomy for intraductal carcinoma (DCIS), the sentinel lymph node is not excised during the primary surgery but only marked for identification. If the final histological examination confirms invasive cancer, delayed surgery is performed to remove the sentinel lymph node that was marked during the initial surgery. primary endpoint : The success rate of identifying the sentinel lymph node that was marked during the primary surgery in cases where the final histological examination confirms invasive cancer is evaluated. addendum) The previously documented Breast-Conserving Surgery has been corrected to reflect the accurate procedure of Total Mastectomy.

Eligibility

Age: 20 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients aged 20 to 75 years old.
* Patients diagnosed with DCIS through histological examination.
* Patients undergoing mastectomy

Exclusion Criteria:

* In cases where the histopathological findings of the tissue examination indicate suspicious invasive lesions.
* In cases where imaging tests or physical examinations suggest possible lymph node metastasis.
* In patients who have previously undergone axillary lymph node surgery on the same side as the current procedure.
* Pregnant patients.

Conditions3

Breast CancerCancerDCIS

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.